Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026)
Pacific Biosciences Of California (PACB) recorded quarterly Amortization - Intangibles of $183000.0 in Q1 2026, up 100.05% quarter-over-quarter from -$358.8 million in Q4 2025, and down 99.95% on a YoY basis from $362.0 million in Q1 2025.
Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026) Analysis & Trends
Pacific Biosciences Of California's Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $183000.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles fell 99.95% year-over-year to $183000.0; the TTM figure through Mar 2026 stood at -$357.0 million (down 195.83% YoY), while the FY2025 annual figure was $4.9 million, down 72.82% from the prior year.
- Amortization - Intangibles was $183000.0 for Q1 2026 at Pacific Biosciences Of California, up from -$358.8 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $362.0 million in Q1 2025 to a low of -$358.8 million in Q4 2025.
- Historically, Amortization - Intangibles has averaged $2.0 million across 5 years, with a median of $833000.0 in 2025.
- Biggest YoY gain for Amortization - Intangibles was 6475.41% in 2025; the steepest drop was 7851.44% in 2025.
- A 5-year view of Amortization - Intangibles shows it stood at $733000.0 in 2022, then surged by 638.88% to $5.4 million in 2023, then slipped by 14.53% to $4.6 million in 2024, then tumbled by 7851.44% to -$358.8 million in 2025, then jumped by 100.05% to $183000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $183000.0 (Q1 2026), -$358.8 million (Q4 2025), and $833000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 426.62 Mn | 150.66 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | -358.81 Mn |
| Sep 30, 2025 | 833,000.00 |
| Jun 30, 2025 | 833,000.00 |
| Mar 31, 2025 | 362.04 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 741,000.00 |
| Dec 31, 2022 | 733,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 183,000.00 |
| Dec 31, 2021 | -123,000.00 |